Stay tuned and follow the latest
developments and news in Molecular Oncology.
Approximately 8,000 women with early breast cancer in Greece were able to avoid chemotherapy thanks to Oncotype DX®’s decision guidance This year marks 15 years since the introduction of the […]
Read More
The study by the Genekor Scientific Team, titled “RediScore: Prospective Validation of a Pipeline for Homologous Recombination Deficiency Analysis,” was published in Oncology Letters The study by the Genekor Scientific […]
Read More
prime DXThe prime DX assay provides a detailed blueprint of tumor biology, which is used by the physician to design the most effective individualized treatment plan for the patient.It includes […]
Read More
W4O Hellas & ARTE in collaboration with Genekor Medical S.A give women the opportunity to do a Free Genetic Test for hereditary predisposition to breast-ovarian cancer. The company Genekor actively […]
Read More
3 Scientific Papers have been accepted by ASCO, to be presented at this year’s conference in June. Genekor scientists, Hospitals and Doctors participated in the investigations, presenting substantial findings concerning […]
Read More
. Nikos Tsoulos MSc, MBA, PhDc, Biochemist, CEO, GeneKor Medical SA gave a speech entitled “The present and future of biomarkers in the Greek health system” he stated that today, […]
Read More
In the context of the 29th Hellenic Congress of Clinical Oncology (29th ESKO) held on April 5-8, 2023 in Athens at the Athenaeum Intercontinental Hotel, Genekor played an active role. […]
Read More
The outcome of the Study was that information obtained from genetic analysis, especially from an integrated NGS analysis such as WES and WGS, is valuable for the diagnosis and individualized […]
Read More
The new publication of the Genekor Scientific Team on: CNV and RNA analysis reveal a germline pathogenic duplication of MSH2 exon 15 in a family with Lynch syndrome: A case […]
Read More